These findings indicated that CDC7i, in combination with Olaparib, can stimulate anti‐tumor immune responses through promoting antigen presentation and activating the cGAS/STING pathway, resulting in interferon‐induced immune response. This evidence concerns the gene CGAS and neoplasm.